August 13, 2021
1 min read

Decision on Covaxin emergency authorisation expected by Sept: MEA

The World Health Organisation has said the agency expects to make a decision next month on an emergency authorisation for the Indian-made COVID-19 vaccine….reports Asian Lite News

The Ministry of External Affairs (MEA) on Thursday said a decision on emergency authorisation for the Covaxin Covid-19 vaccine made by Bharat Biotech is expected to be announced by September as the World Health Organisation (WHO) takes 6-8 weeks to grant the emergency use listing.

In a media briefing, MEA spokesperson Arindam Bagchi said, “Covaxin submitted its application on July 9 so we are expecting a response by September as it takes 6-8 weeks for the WHO to grant the EUL.”

External Affairs Minister S Jaishankar had made a similar statement at the CII annual event.

The World Health Organisation has said the agency expects to make a decision next month on an emergency authorisation for the Indian-made COVID-19 vaccine.

Last week, Bharat Biotech’s Covaxin received a Good Manufacturing Practices (GMP) compliance certificate from Hungary. The certificate of GMP is now listed on the EudraGMDP database which is the collection of records of the European Community of manufacturing authorisations and certificates of good manufacturing practice, Bharat Biotech said.

Asked about the actions taken by the government on easing Covid travel restrictions, the MEA Spokesperson said, “There are many countries where Covid restrictions are there. Not just students, other people who would like to travel are facing problems. As I have said earlier, we attach high importance to ensuring ease of these restrictions whether they live abroad for education or employment. We have been actively taking up this matter at various levels including at the ministerial levels with all of the countries. I am happy to see some forward movements with some of the countries. MEA will continue to attach high priority to this issue.” (India News Network)

ALSO READ: No compromise on Covaxin quality, says Bharat Biotech

ALSO READ: Nod for proposal to study mixing of Covid-19 vaccine doses

Previous Story

India and Australia likely to hold maiden two plus two meeting next month

Next Story

Right to shelter doesn’t mean govt housing for unlimited period: SC

Latest from -Top News

No Ceasefire Deal, Says Tehran

Iran’s Foreign Minister Abbas Araghchi says no “agreement” on ceasefire between Israel and Iran…reports Asian Lite News Uncertainty and scepticism mounted on Monday after a surprise ceasefire announcement by the United States,

Awami League Blasts Yunus ‘Propaganda’

Sheikh Hasina’s party slammed Ordinance No. 30, 2025, calling state recognition of the event an attempt to legitimise an “unconstitutional and unethical conspiracy….reports Asian Lite News Bangladesh’s ruling Awami League has strongly

Pakistan Snubs US at UN

Ahmad said that Pakistan, in collaboration with its all-weather friend, China and its ally, Russia, was circulating a draft resolution for the Council to adopt….reports Asian Lite News Despite the high-profile lunch

Violence against children hit unprecedented levels

In Somalia, it reported 2,568 violations against 1,992 children.In Nigeria, 2,436 grave violations were reported against 1,037 children The UN kept Israeli forces on its blacklist of countries that violate children’s rights

Japan Cancels U.S. Talks

The cancellation also coincides with Japan’s upcoming upper house elections on July 20, which are expected to test Ishiba’s fragile minority coalition Japan has cancelled a planned high-level security meeting with the
Go toTop

Don't Miss

India’s first Bharat Gaurav tourist train flagged off from Delhi

Nepal and India had long ago agreed to build the

Indian Textile Inc rolls out the red carpet

The participants deliberated on the potential of the Indian textile